Earnings

UiPath Shares Dip as Analysts Seek Faster AI Revenue Growth

UiPath shares slipped 0.7% to $11.17 after a solid fiscal first quarter, as investor focus shifted to modest ARR growth and cautious analyst outlooks.

James Calloway · · · 3 min read · 3 views
UiPath Shares Dip as Analysts Seek Faster AI Revenue Growth
Mentioned in this article
MSFT $411.74 -1.18% NOW $114.19 +1.55% PATH $11.17 -0.62% QQQ $744.21 -0.26% SPY $754.24 -0.70%

UiPath (PATH) shares edged lower on Monday, closing at $11.17, a decline of 0.7%, despite the automation software company reporting a robust fiscal first quarter and lifting its full-year guidance. The stock touched an intraday low of $10.91, underperforming the broader technology sector, as the Invesco QQQ Trust (QQQ) rose approximately 1.6% and the SPDR S&P 500 ETF (SPY) gained 0.2%.

Quarterly Results Beat Expectations

UiPath reported fiscal first-quarter revenue of $418 million, a 17% increase year-over-year, and annual recurring revenue (ARR) of $1.901 billion, up 12% from the prior year. The company also achieved GAAP operating income of $28 million, a milestone that CEO Daniel Dines highlighted as a move "from pilot to production" for its agentic AI products. COO and CFO Ashim Gupta noted that this marked the first quarter of GAAP profitability for the company.

Wall Street Remains Cautious

Despite the upbeat results, analysts expressed caution regarding the pace of ARR growth. Morgan Stanley analyst Sanjit Singh lowered his price target on UiPath to $15 from $17, maintaining an Equal Weight rating. Singh characterized the quarter as solid but pointed to "modest ARR flow-through" that leaves the forward outlook in "show-me" territory. Similarly, BofA Securities raised its price target to $13 from $12 but kept an Underperform rating, stating it needs more evidence of sustainable ARR acceleration before turning more positive.

Guidance Reflects Optimism

For the fiscal second quarter, UiPath expects revenue between $395 million and $400 million, with ARR of $1.929 billion to $1.934 billion as of July 31. The company also raised its full-year fiscal 2027 revenue forecast to a range of $1.776 billion to $1.781 billion, up from the prior outlook of $1.754 billion to $1.759 billion.

Competitive Landscape Intensifies

UiPath faces mounting competition from larger enterprise software players. ServiceNow (NOW) has been promoting its AI agents integrated into enterprise workflows, while Microsoft (MSFT) is aggressively pushing its Copilot and agent tools across its suite of business applications. Both companies target similar corporate budgets, making the competitive environment increasingly challenging. ServiceNow shares rose about 1.6% on Monday, while Microsoft fell 1.2%.

However, UiPath also maintains a partnership with Microsoft, leveraging its Azure-based platform to deliver agentic automation within Microsoft environments. A 2025 integration allows developers to embed UiPath automations and AI agents directly into Microsoft Copilot Studio, providing a potential avenue for growth.

Risks and Outlook

UiPath's latest quarterly filing highlighted several risk factors, including macroeconomic volatility, government efficiency initiatives, foreign exchange fluctuations, reliance on cloud and large language model providers, and the emergence of disruptive technologies. If customers delay large-scale automation projects or if larger platforms offer similar tools at lower prices, the company's recent margin improvements may not be sufficient to drive a stock re-rating.

The next key investor event is UiPath's annual meeting scheduled for June 25. Until then, the stock is likely to trade less on headline beats and more on the fundamental question of whether AI agents can translate into faster ARR growth.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →